Circulation · 2004
Safety of statins: focus on clinical pharmacokinetics and drug interactions.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bellosta Stefano, Paoletti Rodolfo, Corsini Alberto
Аннотация
Statin monotherapy is generally well tolerated, with a low frequency of adverse events. The most important adverse effects associated with statins are myopathy and an asymptomatic increase in hepatic transaminases, both of which occur infrequently. Because statins are prescribed on a long-term basis, however, possible interactions with other drugs deserve particular attention, as many patients will typically receive pharmacological therapy for concomitant conditions during the course of statin treatment. This review summarizes the pharmacokinetic properties of statins and emphasizes their clinically relevant drug interactions.
Предметные рубрики MeSH
Binding, CompetitiveBiological AvailabilityCalcium Channel BlockersChemical and Drug Induced Liver InjuryCitrusCytochrome P-450 CYP2D6Cytochrome P-450 CYP3ACytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme SystemDrug InteractionsFenofibrateGemfibrozilHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLiver Function TestsPolymorphism, GeneticPolymyositisRhabdomyolysis